Algeria vs Oman: Share of people with HIV who receive antiretroviral therapy
Algeria
68.0%
in 2024
Oman
68.0%
in 2024
Algeria rank
82nd
Oman rank
82nd
Share of people with HIV who receive antiretroviral therapy over time
- Algeria
- Oman
How they compare
Algeria currently reports 68.0% against 68.0% in Oman, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Oman ahead.
Algeria ranks 82nd and Oman ranks 82nd of 143 countries.
Across the 3 decades both report, Algeria averaged higher in 2 and Oman in 1.
Head to head by decade
| Decade | Algeria | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.3% | 18.5% | 8.2% | Oman |
| 2010s | 46.5% | 38.5% | 8.0% | Algeria |
| 2020s | 70.8% | 61.4% | 9.4% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Algeria or Oman?
- Algeria, at 68.0% against 68.0% in Oman as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Algeria and Oman?
- 0.0%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Oman?
- 25 years are reported by both, from 2000 to 2024.
- How do Algeria and Oman rank globally for share of people with hiv who receive antiretroviral therapy?
- Algeria ranks 82nd and Oman ranks 82nd of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.